Terapi modifikasi penyakit pada lupus eritematosus sistemik untuk manifestasi ekstrarenal Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald van Vollenhoven, Murray B Urowitz
22 May 2024
Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial Jane Salmon, Daniel J Wallace, Violeta Rus, Addison Cox, Claire Dykas, Brooke Williams, Yunpeng Ding, Petter-Arnt Hals, Line Johnsen, Peter E Lipsky
14 July 2024
Effects of systemic lupus erythematosus on the brain: a systematic review of structural MRI findings and their relationships with cognitive dysfunction Diana Valdés Cabrera, Tala El Tal, Ibrahim Mohamed, Santiago Eduardo Arciniegas, Stephanie Fevrier, Justine Ledochowski, Andrea M Knight
17 August 2024
Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS) Daisuke Hiraoka, Jun Ishizaki, Jun Yamanouchi, Takatsugu Honda, Toshiyuki Niiya, Erika Horimoto, Kenta Horie, Hitoshi Yamasaki, Takuya Matsumoto, Koichiro Suemori, Hitoshi Hasegawa, Katsuto Takenaka
8 July 2024
Infezione intercorrente come fattore di rischio per le riacutizzazioni della malattia nei pazienti con lupus eritematoso sistemico Fatma el Hadiyen, Michel W P Tsang-A-Sjoe, Birgit I Lissenberg-Witte, Alexandre E Voskuyl, Irene E M Bultink
1 July 2024
Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis Irene Altabás-González, Iñigo Rua-Figueroa, Coral Mouriño, Karen Roberts, Norman Jimenez, Julia Martinez-Barrio, María Galindo, Jaime Calvo Alén, Victor del Campo Pérez, Esther Uriarte Itzazelaia, Eva Tomero, Mercedes Freire-González, Víctor Martínez Taboada, Eva Salgado, Paloma VelaSee the full list of authors
3 August 2024
When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosus Chiara Tani, Michele Maffi, Giancarlo Cascarano, Viola Signorini, Dina Zucchi, Marina Menchini, Chiara Stagnaro, Linda Carli, Elena Elefante, Francesco Ferro, Chiara Cardelli, Maria Laura Manca, Marta Mosca
23 July 2024
SARS-CoV-2 spike aggravates lupus nephritis and lung fibrosis in systemic lupus erythematosus Yeon Su Lee, Jin Seok Woo, JooYeon Jhun, Jeong Won Choi, A Ram Lee, Kun Hee Lee, Haeyoun Choi, Sung-Hwan Park, Mi-La Cho
30 September 2024
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD) Jessica Ellis, Neil McHugh, John D Pauling, Ian N Bruce, Rachel Charlton, Anita McGrogan, Sarah Skeoch
27 July 2024
Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan Yu-Chia Chen, Ting-Yuan Liu, Hsing-Fang Lu, Chung-Ming Huang, Chi-Chou Liao, Fuu-Jen Tsai
9 May 2024
Alignment of contraception use with the ACR reproductive health guidelines in women with systemic lupus erythematosus within the RISE registry Megan E B Clowse, Jing Li, Amanda Snyderman, Gabriela Schmajuk
24 August 2024
Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis Liling Zhao, Wenwen Wang, Lijun Wu, Tong Wu, Jianxin Tu, Xue Wu, Fangfang Sun, Huihua Ding, Nan Shen, Huaxiang Wu, Jing Zhu, Li Sun, Shuang Ye
28 May 2024
Eficacia real del belimumab en pacientes con lupus en China: protocolo de estudio de cohorte observacional FIABLE Liya Fan, Zhiliu Tang, Xin He, Xintong He, Zhuoli Zhang, Patricia Juliao
11 July 2024
SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus Regina Rendas-Baum, Wen-Hung Chen, Kerry Gairy, Seth Anderson, Christine Henning, Anne Hammer, Mark Kosinski
8 May 2024
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS Maria Dall'Era, Kenneth Kalunian, Neil Solomons, Matt Truman, Lucy S Hodge, Ernie Yap, Anca D Askanase
9 November 2024
Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history Kimberly DeQuattro, Laura Trupin, Sarah Patterson, Stephanie Rush, Caroline Gordon, Kurt J Greenlund, Kamil E Barbour, Cristina Lanata, Lindsey A Criswell, Maria Dall'Era, Jinoos Yazdany, Patricia P Katz
15 May 2024
Discrepant anti-dsDNA testing between EliA and Crithidia in ANA negative samples: just a false positive? José María López-Ortega, Adrián Mayo-Juanatey, Pablo Sanz-García, Juan José Alegre-Sancho
5 August 2024
Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study Jinlu Ma, Lin Zhang, Mengxue Yan, Zhichun Liu, Leixi Xue
10 June 2024
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus Yanjie Hao, Dylan Hansen, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian Jan Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi HarigaiSee the full list of authors
18 September 2024
Monoclonal gammopathy in systemic lupus erythematosus is associated with distinctive clinical course, malignancy and mortality rate: a single-centre retrospective cohort study Andzelika Siwiec-Kozlik, Pawel Kozlik-Siwiec, Magdalena Spalkowska, Mariusz Korkosz, Joanna Kosalka-Wegiel
30 August 2024
